ReNewVax Ltd

LIVERPOOL, X0 · Founded 2022 · CIK 0001979470 · Biotech · Private

Universal pneumococcal vaccine targeting ~100 Streptococcus pneumoniae variants

renewvax.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.0M
1 Form D · May 2023
41 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3307SilverCeuticals Inc.—$5.0M
3308ORF Biologics, Inc.—$2.5M
3309Blue Marlin Data Fund, LLC—$16M
3310ReNewVax Ltd—$3.0M
3311SYNAPTICURE INC—$40M
3312Ampersand Health, LLC—$7.7M
3313CAPTOZYME, INC.—$3.4M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Neil MurrayDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.